New Registry Study Showcases Efficacy of GammaTile in Treating Brain Metastases A recent multicenter study highlights the effectiveness of GammaTile for local tumor control in brain metastases patients, showcasing a 92.3% success rate.

New Registry Study Showcases Efficacy of GammaTile in Treating Brain Metastases #United_States #Tempe #GammaTile #GT_Medical_Technologies #Brain_Metastases

New Clinical Research Validates Efficacy of GammaTile for Treating Recurrent Brain Metastases GT Medical Technologies announces new data highlighting GammaTile's effectiveness in treating recurrent brain metastases, offering hope for patients facing limited options.

New Clinical Research Validates Efficacy of GammaTile for Treating Recurrent Brain Metastases #United_States #Tempe #GammaTile #GT_Medical_Technologies #Brain_Metastases